Drugmaker, Retailers Strike Deal In Loestrin Antitrust MDL

By Anne Cullen (May 20, 2019, 6:08 PM EDT) -- Lupin Pharmaceuticals cut a deal that will allow it to escape antitrust claims leveled against it by Walgreens, CVS and other retailers that it conspired with two other pharmaceutical companies to keep generic versions of birth control drug Loestrin off the market....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!